Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
InMed Pharmaceuticals Inc. (INM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2022 |
8-K
| Resignation/termination of a director, Appointed a new director|
Docs:
|
"InMed Announces Changes to its Board of Directors Vancouver, BC – August 9, 2022 – InMed Pharmaceuticals Inc. , a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment of Nicole Lemerond to its Board of Directors, effective immediately. Nicole Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. She has significant experience executing complex transactions, managing diligence processes, raising capital and structuring balance sheets. Throughout her career, Ms. Lemerond has worked with public and private company management teams and boards to increase stakeholder value. She established and led healthcare groups at l..." |
|
| 02/23/2022 |
8-K
| Resignation/termination of a director, Appointed a new director |
|
|